Advertisement

Topics

Cytovia, Inc., Immune Pharma???s Oncology Subsidiary, Announces The Publication Of New Results In And Filing Of A World-Wide Patent Protecting The Use Of Ceplene In Chronic Myeloid Leukemia (CML)

20:00 EDT 6 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Cytovia, Inc., Immune Pharma???s Oncology Subsidiary, Announces The Publication Of New Results In And Filing Of A World-Wide Patent Protecting The Use Of Ceplene In Chronic Myeloid Leukemia (CML)

NEXT ARTICLE

More From BioPortfolio on "Cytovia, Inc., Immune Pharma???s Oncology Subsidiary, Announces The Publication Of New Results In And Filing Of A World-Wide Patent Protecting The Use Of Ceplene In Chronic Myeloid Leukemia (CML)"

Quick Search
Advertisement